NLS Pharmaceutics AG (NLSP)
NASDAQ: NLSP · IEX Real-Time Price · USD
0.164
+0.015 (9.77%)
At close: May 17, 2024, 4:00 PM
0.165
+0.001 (0.55%)
After-hours: May 17, 2024, 7:48 PM EDT
NLS Pharmaceutics AG Market Cap
NLS Pharmaceutics AG has a market cap or net worth of $6.28 million as of May 17, 2024. Its market cap has decreased by -84.76% in one year.
Market Cap
6.28M
Enterprise Value
7.01M
1-Year Change
-84.76%
Ranking
Category
Stock Price
$0.16
Market Cap Chart
Since the IPO on January 29, 2021, NLS Pharmaceutics AG's market cap has decreased from $48.88M to $6.28M, a decrease of -87.16%. That is a compound annual growth rate of -46.35%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 16, 2024 | 5.30M | 1.92% |
May 15, 2024 | 5.20M | -3.70% |
May 14, 2024 | 5.40M | 8.00% |
May 13, 2024 | 5.00M | - |
May 10, 2024 | 5.00M | - |
May 9, 2024 | 5.00M | - |
May 8, 2024 | 5.00M | - |
May 7, 2024 | 5.00M | 2.04% |
May 6, 2024 | 4.90M | - |
May 3, 2024 | 4.90M | - |
May 2, 2024 | 4.90M | 2.08% |
May 1, 2024 | 4.80M | -4.00% |
Apr 30, 2024 | 5.00M | -1.96% |
Apr 29, 2024 | 5.10M | 4.08% |
Apr 26, 2024 | 4.90M | 4.26% |
Apr 25, 2024 | 4.70M | 4.44% |
Apr 24, 2024 | 4.50M | -2.17% |
Apr 23, 2024 | 4.60M | - |
Apr 22, 2024 | 4.60M | -2.13% |
Apr 19, 2024 | 4.70M | - |
Apr 18, 2024 | 4.70M | - |
Apr 17, 2024 | 4.70M | -4.08% |
Apr 16, 2024 | 4.90M | -2.00% |
Apr 15, 2024 | 5.00M | -7.41% |
Apr 12, 2024 | 5.40M | -1.82% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Avinger | 6.09M |
Titan Pharmaceuticals | 5.99M |
Creative Medical Technology Holdings | 5.93M |
Heart Test Laboratories | 5.89M |
Lipella Pharmaceuticals | 5.80M |
Processa Pharmaceuticals | 5.77M |
Adial Pharmaceuticals | 5.76M |
Soligenix | 5.74M |